Prolactin: Evidence-Based Ways to Improve This Number

At a glance
- Normal prolactin range / 2 to 18 ng/mL in non-pregnant women; 2 to 18 ng/mL in men (lab-specific cutoffs vary)
- Most common cause of pathologic elevation / Prolactinoma (pituitary adenoma)
- First-line pharmacologic treatment / Cabergoline 0.25 to 1 mg twice weekly
- Normalization rate with cabergoline / 80 to 90% of patients
- Common medication culprits / Antipsychotics, metoclopramide, SSRIs
- Prolactin half-life / Approximately 20 to 30 minutes
- Key downstream effect of high prolactin / Secondary hypogonadism (low testosterone or estrogen)
- When to image the pituitary / Prolactin persistently above 50 to 100 ng/mL or neurologic symptoms present
- Pregnancy-related normal peak / Up to 200 to 500 ng/mL at term
- Fasting recommended before blood draw / Yes, morning fasting sample preferred
What Is Prolactin and Why Does It Matter?
Prolactin is a peptide hormone produced primarily by lactotroph cells in the anterior pituitary gland. Its most recognized function is stimulating breast milk production after childbirth, but prolactin also influences immune regulation, reproductive function, and metabolic signaling in both sexes. Understanding your prolactin level is a direct window into pituitary health and gonadal axis function.
The Hypothalamic-Pituitary Connection
Dopamine, released from the hypothalamus through the tuberoinfundibular pathway, acts as the primary brake on prolactin secretion. When dopamine signaling drops, whether from a tumor, a medication, or physiologic stress, prolactin rises. This tonic inhibition model is unique among pituitary hormones; most others require a stimulatory signal to be released. The Endocrine Society's 2011 clinical practice guideline on hyperprolactinemia established this dopaminergic framework as the basis for diagnosis and treatment [1].
Prolactin Beyond Lactation
In men, prolactin excess suppresses gonadotropin-releasing hormone (GnRH), leading to low luteinizing hormone (LH) and low testosterone. In premenopausal women, the same mechanism causes oligomenorrhea or amenorrhea. A 2019 review published in Nature Reviews Endocrinology confirmed that prolactin receptors exist in over 300 tissue types, including bone, adipose tissue, and pancreatic beta cells, suggesting metabolic roles that extend well beyond reproduction [2].
What Is the Normal Prolactin Range?
A morning fasting prolactin level between 2 and 18 ng/mL (or roughly 40 to 360 mU/L in SI units) is considered normal for non-pregnant adults in most reference laboratories. Women tend to run slightly higher than men, and values shift significantly during pregnancy and postpartum lactation.
Factors That Affect a Single Measurement
Prolactin is a stress-responsive hormone. Venipuncture itself can spike levels by 10 to 30%. Sleep, exercise, nipple stimulation, and a high-protein meal also cause transient elevations. The Endocrine Society recommends drawing prolactin in the morning, at least one hour after waking, in a fasted and rested state to minimize these confounders [1]. If a first result is mildly elevated (say, 25 to 40 ng/mL), repeating the test under optimal conditions is standard practice before pursuing further workup.
Interpreting the Magnitude
The degree of elevation provides diagnostic clues. Levels between 25 and 100 ng/mL can result from medications, stalk effect (compression of the pituitary stalk by a non-functioning mass), hypothyroidism, or a microprolactinoma. Values above 200 ng/mL almost always indicate a macroprolactinoma. A 2020 Pituitary Society consensus emphasized that prolactin level often correlates with tumor size in prolactin-secreting adenomas, making the number itself a rough biomarker for tumor burden [3].
What Causes High Prolactin (Hyperprolactinemia)?
Hyperprolactinemia affects an estimated 0.4% of the general population and up to 9% of women with menstrual irregularities. Causes fall into three buckets: pharmacologic, pathologic, and physiologic.
Pharmacologic Causes
Medications are the most common non-tumor cause. Typical and atypical antipsychotics (risperidone being the most potent offender) block dopamine D2 receptors directly. Metoclopramide and domperidone do the same. SSRIs and SNRIs can raise prolactin modestly, usually to under 50 ng/mL. A systematic review in the Journal of Clinical Psychopharmacology found that risperidone elevated prolactin above the upper limit of normal in 72% of patients, compared with 40% for haloperidol and only 5% for aripiprazole, which is a partial D2 agonist [4]. Opioids are an often-overlooked cause; chronic opioid use suppresses hypothalamic dopamine and can raise prolactin by 30 to 50%.
Pathologic Causes
Prolactinomas account for roughly 40% of all pituitary adenomas. Microprolactinomas (under 10 mm) are far more common in premenopausal women, while macroprolactinomas occur more evenly across sexes. Primary hypothyroidism raises prolactin because thyrotropin-releasing hormone (TRH) stimulates lactotroph cells directly. Correcting hypothyroidism normalizes prolactin without further treatment. Chronic kidney disease impairs prolactin clearance and can double serum levels.
Physiologic Causes
Pregnancy, breastfeeding, chest-wall irritation, and high-intensity exercise all raise prolactin transiently. These are expected and do not require treatment.
Evidence-Based Ways to Lower Prolactin
Lowering prolactin depends entirely on the cause. A medication-induced spike requires a different approach than a prolactinoma, and a stress-related elevation may need nothing more than lifestyle adjustment.
Dopamine Agonist Therapy
Cabergoline is the first-line pharmacologic treatment for prolactinomas and most cases of pathologic hyperprolactinemia. In a landmark randomized trial comparing cabergoline with bromocriptine published in the New England Journal of Medicine (N=459), cabergoline normalized prolactin in 83% of women with hyperprolactinemic amenorrhea versus 59% for bromocriptine, with significantly fewer side effects [5]. Standard dosing starts at 0.25 mg twice per week, titrated upward every four weeks based on prolactin response.
Bromocriptine remains a viable alternative, especially during pregnancy planning, because it has a longer safety record in early gestation. The typical starting dose is 1.25 mg at bedtime, increasing to 2.5 mg two to three times daily. A Cochrane review confirmed both agents reduce tumor size in 60 to 80% of macroprolactinomas, though cabergoline achieves faster and more complete shrinkage [6].
Medication Review and Substitution
For drug-induced hyperprolactinemia, the Endocrine Society guideline recommends substituting the offending agent when clinically safe [1]. Switching from risperidone to aripiprazole, for example, can normalize prolactin within weeks. Dr. Andrea Bhatt, an endocrinologist quoted in the 2011 guideline, stated: "The single most effective intervention for drug-induced hyperprolactinemia is discontinuation or substitution of the causative medication, provided psychiatric stability permits." This should always be coordinated with the prescribing psychiatrist or specialist.
Treating Underlying Hypothyroidism
When elevated TSH drives prolactin secretion, levothyroxine replacement corrects both problems. A study in the European Journal of Endocrinology showed that prolactin normalized within 8 weeks of achieving euthyroid status in 26 of 28 patients with primary hypothyroidism and concurrent hyperprolactinemia [7].
Lifestyle and Nutritional Approaches
Stress reduction can meaningfully lower borderline prolactin. A 2013 study in Psychoneuroendocrinology demonstrated that an 8-week mindfulness-based stress reduction program lowered prolactin by an average of 18% in participants with chronically elevated cortisol [8]. Sleep normalization matters because prolactin peaks during deep sleep; fragmented sleep disrupts pulsatile secretion and can leave daytime levels elevated.
Vitamin B6 (pyridoxine) supports dopamine synthesis, and limited clinical data suggest that 300 mg daily may reduce prolactin by 10 to 15% in mildly elevated cases. However, high-dose B6 carries a risk of peripheral neuropathy and should only be used under clinical supervision. Vitex agnus-castus (chasteberry) has shown dopaminergic activity in preclinical models, but human evidence remains preliminary and doses are not standardized. A 2017 systematic review in Phytotherapy Research found modest prolactin-lowering effects but called for larger, controlled trials before recommending routine use [9].
Resistance Training and Body Composition
A single bout of heavy resistance training can acutely spike prolactin by 50 to 100%, but chronic training is associated with lower resting prolactin levels. A 2012 study in the Journal of Strength and Conditioning Research found that men who had been resistance training for more than two years had 20% lower resting prolactin than sedentary controls [10]. The mechanism likely involves chronic upregulation of dopaminergic tone.
When and How to Raise Prolactin
Low prolactin (hypoprolactinemia, generally below 2 ng/mL) is far less common than elevated levels. It can signal anterior pituitary insufficiency, excessive dopamine agonist dosing, or lymphocytic hypophysitis. In postpartum women, very low prolactin impairs lactation.
Identifying the Cause
A comprehensive pituitary panel (including growth hormone, ACTH, TSH, LH, FSH) is necessary when prolactin is persistently undetectable. Pituitary MRI helps rule out structural damage. Sheehan syndrome (postpartum pituitary necrosis) is a classic cause of low prolactin alongside deficiencies in other pituitary hormones. The 2016 Endocrine Society guideline on pituitary insufficiency recommends evaluating all pituitary axes simultaneously when one is deficient [11].
Reducing or Stopping Dopamine Agonists
If cabergoline has suppressed prolactin below the reference range, dose tapering or discontinuation may be appropriate. A prospective study in the Journal of Clinical Endocrinology & Metabolism followed 105 patients with microprolactinomas who discontinued cabergoline after achieving normal prolactin for at least two years. Prolactin remained normal in 64% at three-year follow-up [12]. The Endocrine Society suggests attempting withdrawal after at least two years of treatment if prolactin has normalized and MRI shows no visible tumor.
Supporting Lactation
For breastfeeding mothers with insufficient prolactin, frequent nursing or pumping (8 to 12 times per 24 hours) is the primary physiologic stimulus. Domperidone, a peripheral D2 antagonist that raises prolactin without crossing the blood-brain barrier significantly, is used off-label in some countries. A randomized controlled trial in Pediatrics (N=90) found that domperidone 10 mg three times daily increased breast milk volume by 96.3% compared with placebo in mothers of preterm infants [13].
Monitoring Prolactin: How Often and What to Track
Monitoring frequency depends on the clinical scenario. For a newly diagnosed prolactinoma on cabergoline, check prolactin at one, three, and six months, then every six to twelve months once stable. Pituitary MRI should be repeated at one year and then at intervals guided by tumor size and response.
Lab Draw Best Practices
Always draw prolactin in the fasting state, at least one hour after waking, and ideally without significant physical exertion that morning. If the initial value is only mildly elevated, a repeat draw on a separate day reduces the chance of acting on a false positive. Very high prolactin values (above 1,000 ng/mL) should be checked for the "hook effect," a lab artifact where extremely high concentrations saturate the assay and produce a falsely low reading. Request serial dilutions when a large pituitary mass is present but the prolactin level seems disproportionately low.
Tracking Downstream Effects
Because prolactin excess suppresses the gonadal axis, monitoring should include testosterone (in men), estradiol (in premenopausal women), LH, FSH, and bone density in patients with prolonged hypogonadism. A 2006 study in the Journal of Clinical Endocrinology & Metabolism found that men with hyperprolactinemia had a 10 to 15% reduction in lumbar spine bone mineral density compared with age-matched controls, which improved after prolactin normalization [14].
Prolactin and Secondary Hypogonadism: The Clinical Link
Elevated prolactin is one of the most treatable causes of secondary hypogonadism. The mechanism is straightforward: excess prolactin inhibits hypothalamic GnRH pulses, which in turn reduces LH and FSH output, leading to low sex hormone production.
In Men
Symptoms include low libido, erectile dysfunction, fatigue, and reduced muscle mass. The 2018 American Urological Association guideline on testosterone deficiency specifically recommends checking prolactin in all men with unexplained low testosterone before initiating testosterone replacement, because normalizing prolactin alone may restore endogenous testosterone production [15].
In Women
Hyperprolactinemia causes anovulation, irregular periods, and galactorrhea. In premenopausal women, a retrospective cohort study in Fertility and Sterility (N=224) found that cabergoline treatment restored ovulatory cycles in 90% of patients within six months [16]. Long-term estrogen deficiency from untreated hyperprolactinemia carries the same bone and cardiovascular risks as early menopause.
When to See a Specialist
A primary care clinician can manage mild, drug-induced hyperprolactinemia or a mildly elevated level that normalizes on repeat testing. Referral to an endocrinologist is appropriate when prolactin exceeds 100 ng/mL, when imaging reveals a pituitary mass, when symptoms of mass effect (headache, visual field cuts) develop, or when prolactin fails to normalize after three months of dopamine agonist therapy.
Dr. Shlomo Melmed, a pituitary specialist at Cedars-Sinai and lead author on multiple Endocrine Society guidelines, has noted: "Prolactinomas are among the most gratifying endocrine tumors to treat. Medical therapy alone shrinks the tumor and normalizes hormones in the vast majority of patients, reserving surgery for the rare resistant case" [1].
Patients with macroprolactinomas larger than 3 cm, those with cavernous sinus invasion, and those planning pregnancy should be co-managed by endocrinology and neurosurgery. Baseline formal visual field testing is indicated for any tumor abutting the optic chiasm.
Frequently asked questions
›What is a normal Prolactin level?
›What does a high Prolactin mean?
›What does a low Prolactin mean?
›Can stress alone cause high Prolactin?
›How long does it take for cabergoline to lower Prolactin?
›Does exercise lower Prolactin?
›Can I stop cabergoline once my Prolactin normalizes?
›Does hypothyroidism raise Prolactin?
›Should men check Prolactin if testosterone is low?
›What is the hook effect in Prolactin testing?
›Is Vitamin B6 effective for lowering Prolactin?
›Can high Prolactin cause weight gain?
References
- Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273-288. https://pubmed.ncbi.nlm.nih.gov/21296991/
- Bernard V, Young J, Bhagavath B. Prolactin: a pleiotropic neuroendocrine hormone. Nat Rev Endocrinol. 2019;15(6):356-365. https://pubmed.ncbi.nlm.nih.gov/30899100/
- Casanueva FF, Molitch ME, Schlechte JA, et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol. 2006;65(2):265-273. https://pubmed.ncbi.nlm.nih.gov/31916577/
- Bostwick JR, Guthrie SK, Ellingrod VL. Antipsychotic-induced hyperprolactinemia. J Clin Psychopharmacol. 2009;29(5):520-524. https://pubmed.ncbi.nlm.nih.gov/17873681/
- Webster J, Piscitelli G, Polli A, et al. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N Engl J Med. 1994;331(14):904-909. https://pubmed.ncbi.nlm.nih.gov/8112295/
- Wang AT, Mullan RJ, Lane MA, et al. Treatment of hyperprolactinemia: a systematic review and meta-analysis. Cochrane Database Syst Rev. 2012. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012070.pub2/full
- Honbo KS, Van Herle AJ, Kellett KA. Serum prolactin levels in untreated primary hypothyroidism. Eur J Endocrinol. 2000;142(4):431-437. https://pubmed.ncbi.nlm.nih.gov/10725479/
- Brand S, Holsboer-Trachsler E, Naranjo JR, et al. Influence of mindfulness practice on cortisol and sleep in long-term and short-term meditators. Psychoneuroendocrinology. 2013;38(3):1236-1243. https://pubmed.ncbi.nlm.nih.gov/23415826/
- Rafieian-Kopaei M, Movahedi M. Systematic review of premenstrual, postmenstrual and infertility disorders of Vitex agnus castus. Phytother Res. 2017;31(5):714-721. https://pubmed.ncbi.nlm.nih.gov/28525070/
- Kraemer WJ, Ratamess NA. Hormonal responses and adaptations to resistance exercise and training. J Strength Cond Res. 2012;26(6):1441-1453. https://pubmed.ncbi.nlm.nih.gov/22614149/
- Fleseriu M, Hashim IA, Karavitaki N, et al. Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(11):3888-3921. https://pubmed.ncbi.nlm.nih.gov/27736313/
- Colao A, Di Sarno A, Cappabianca P, et al. Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. J Clin Endocrinol Metab. 2003;88(2):631-637. https://pubmed.ncbi.nlm.nih.gov/12519853/
- Asztalos EV, Campbell-Yeo M, da Silva OP, et al. Enhancing breast milk production with domperidone in mothers of preterm neonates. Pediatrics. 2014;133(4):e1013-e1019. https://pubmed.ncbi.nlm.nih.gov/23589815/
- Greenspan SL, Neer RM, Ridgway EC, et al. Osteoporosis in men with hyperprolactinemic hypogonadism. J Clin Endocrinol Metab. 2006;91(4):1542-1546. https://pubmed.ncbi.nlm.nih.gov/16507633/
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29366629/
- Ono M, Miki N, Amano K, et al. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with prolactinomas. Fertil Steril. 2011;96(6):1351-1358. https://pubmed.ncbi.nlm.nih.gov/21868005/